ALPS Medical Breakthroughs ETF
SBIO
#2356
ETF rank
NZ$0.22 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
NZ$90.13
Share price
-1.59%
Change (1 day)
59.26%
Change (1 year)

Expense ratio and fees for ALPS Medical Breakthroughs ETF (SBIO)

Gross Expense Ratio

Gross Expense Ratio as of January 2026: 0.5%

Net Expense Ratio

Net Expense Ratio as of January 2026: 0.5%